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REVIEW ARTICLE 
ROLE OF RADIOSURGERY IN ARTERIOVENOUS MALFORMATIONS 
Syed Ijlal Ahmed, Gohar Javed*, Saher Naseeb Uneeb**, Syeda Beenish Bareeqa***, 
Manaal Haider†, Syeda Sana Samar††, Armghan Haider Ans†††, Muhammad Tayyab SheraΔ 
Abbasi Shaheed Hospital, Karachi, *Aga Khan University Hospital, Karachi, **Liaquat National Medical College, Karachi, ***Jinnah 
Medical and Dental College, Karachi, †Bahria Medical University, Karachi, ††Jinnah Sindh Medical University, Karachi, †††Services 
Institute of Medical Science, Lahore, ΔKing Edward Medical University, Lahore-Pakistan 
Background: Intracranial arteriovenous malformations (AVMs) consist of an abnormal nidus of 
blood vessels that shunt blood directly from an artery to a vein and thereby bypass an intervening 
capillary bed. AVMs may be found as an incidental finding. They may be associated with 
intracranial haemorrhage, seizures, headaches or neurological deficits. There are different 
treatment options for AVM. These include observation, microsurgery, Stereotactic radio surgery 
(SRS), endovascular embolization and intensity modulated radiotherapy (IMRT). Method: Data 
was collected using searching engines like Pubmed, Google scholar, Embase, Cinahl and Medline. 
MeSH and Non-MeSH terms were used like Arterio-venous malformations, microsurgery, 
endovascular embolization. Results: Multiple interventional radiosurgical techniques have been 
introduced in recent years. The most effective and least risk-associated methods are Stereotactic 
radiosurgery, Microsurgery, Embolization and Intensity modulated radiotherapy (IMRT). 
However, the outcome of such treatment modalities depends upon Site of malformation, grade of 
AVM, patient’s age/gender, dose and volume of radiosurgery. Digital substraction angiography 
(DSA) and MR angiography (MRA) are most suitable methods for the follow-up of AVMs. 
Conclusion: Stereotactic radiosurgery is the most suitable technique for AVMs considering the 
good prognosis and the risks associated with this procedure. However, large AVMs require multi-
disciplinary approach for better results.  
Keywords: Arterio-venous malformations; Stereotactic radio-surgery, Microsurgery; 
Endovascular embolization 
Citation: Ahmed SI, Javed G, Uneeb SN, Bareeqa SB, Haider M, Samar SS, et al. Role of Radiosurgery in Arteriovenous 
malformations; A Comprehensive Literature review. J Ayub Med Coll Abbottabad 2018;30(3):449–57.  
INTRODUCTION 
Intracranial arteriovenous malformations (AVMs) 
consist of an abnormal nidus of blood vessels that 
shunt blood directly from an artery to a vein and 
thereby bypass an intervening capillary bed.1 They 
are intraparenchymal collection of dilated arteries 
and veins which lack normal vascular organization at 
the sub arteriolar level as well as a normal capillary 
bed.2 The incidence of AVM is estimated to be 1.12–
1.34 per 100,000 person/years.3 AVMs may be found 
as an incidental finding. They may be associated with 
intracranial haemorrhage, seizures, headaches or 
neurological deficits. 
There are different treatment options for 
AVM. These include observation, surgical removal 
of AVM, stereotactic radio-surgery (SRS), 
endovascular embolization4 and intensity modulated 
radiotherapy (IMRT). 
Gamma knife, x knife and charged particles 
are included in types of SRS. SRS has a clinical 
obliteration rate of 80%5 with no long term cognitive 
effects6. The outcome of SRS was determined by a 
number of factors. The success rate was increased 
with smaller volume (up to 30 cm3)7, lower grade, 
higher dose, and steeper dose gradient8. 
Complications after SRS include haemorrhage, 
seizures, delayed cysts and other adverse effects. 
Complication risk was increased due to incomplete 
obliteration of the lesion.9 Complication risk was 
dependent on clinical history, previous AVM surgery 
and previous radiation exposure. It was not 
dependent on age or gender.10 The purpose of the 
literature review was to compile all the previous 
research done on this topic. Although there have been 
previous reviews done, however, they are either 
specific to a particular tumour size or a particular 
type of radiosurgery. Since radiosurgery is a common 
modality used in many centres it was essential to 
compile all the different types of radio surgery and 
the effect of this treatment modality with regards to 
different tumour sizes and other factors that 
determine treatment outcome. On the basis of this 
literature review, stereotactic radio surgery was 
considered a good treatment modality due to it being 
a minimally invasive procedure with a high 
obliteration rate and low complication risk. It was 
considered as a good option for tumours that had 
lesser volume but higher grade. However, for 
tumours with greater volume and larger size a 
multimodal approach can be considered such as 
microsurgery combined with radiosurgery, combined 
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embolization and radiosurgery and intensity 
modulated radiotherapy. The latter being the 
preferred choice in children with higher grade and 
larger size of AVM.11  
Radio-surgery is surgery using ionizing 
radiation that precisely destroys targeted areas. In 
SRS, stereotactic refers to a three-dimensional 
coordinate system. This system relates the virtual 
target seen in diagnostic images with the actual target 
position. Among the many treatment options for 
AVM, SRS has become one treatment modality.1,12–14  
The purpose of our study is to discuss radio 
surgery as a treatment modality for AVM and to 
evaluate its outcome. 
Types of SRS 
There are different types of stereotactic radio surgery. 
Among them are Gamma knife which uses photons, 
linear accelerator (LINAC) which uses X-rays and 
charged particles such as helium or protons.15 All 
these types of radio surgery are in use and are equally 
effective. The physical accuracy was comparable 
between different radio surgical methods. Linear 
accelerators are preferred for intermediate sized 
lesions (5–25 cm3).16 However, Semwal et al in a 
more recent study in 2012 published a retrospective 
comparative study that suggested that gamma knife is 
better than x knife (LINAC). Gamma knife having a 
higher performance conformity index (PCI) 
0.664±0.048 as compared to x knife 0.501±0.240 but 
as the distance from the target increases x-knife 
become a better option than gamma knife.17 Beams of 
heavy charged particles, however, are preferred for 
intracranial lesions15 as the complete obliteration rate 
was 94% for smaller lesions, the clinical outcome 
was excellent in 58% of patients and neurological 
complications occurred in 12% of patients. 
After irradiation, there is endothelial cell 
proliferation, vessel wall thickening and closure of 
vessel lumen leading to successful obliteration.18 
Treatment modalities 
1) SRS-Stereotactic radiosurgery is a minimally 
invasive procedure and is considered as an 
effective treatment. In 1992, Steiner et al. 
published an interventional clinical study that 
was done to assess the clinical outcome of 
radio surgery; it suggested that the complete 
obliteration rate of AVM was 79–95%.12 This 
was in line with findings of 2 more articles 
which determined the factors associated with 
AVM radio surgery outcome. In 1998 
Pollock et al published a multivariate analysis 
that found that the AVM obliteration rate was 
80%.1 Chang et al published an interventional 
study in the year 2000 and stated that the 
AVM obliteration rate was 78.9%.14 Besides 
the obliteration rate a cohort study was done 
by Raghunath et al in 2016 to determine the 
cognitive outcomes of radio surgery.2 This 
study stated that there were no long-term 
cognitive effects of this method as the 
outcome rate involving nidus obliteration 
with no new neurological deficits was found 
to be 66.6% and in fact several years later 
there was also improvement of memory after 
treatment. The perseverative responses that is 
the ability to repeat a particular phrase was 
seen to decrease from a value of 26.5–18.2. 
Set shifting that is the ability to 
unconsciously shift from one task to another 
was seen to improve in 11 out of 34 patients. 
This study however mentioned that more 
research is required to assess AVM 
obliteration and its effect on 
neuropsychological outcome because all 
AVMs showed some response at 2 years 
follow up and so effect of obliteration could 
not be analysed.2 B. Shäuble et al in the year 
2004 did a comparative cross-sectional study 
on seizure outcome after radiosurgery and it 
was found to improve with 78% patients 
having an excellent outcome.19  
2) Microsurgery- This treatment modality 
can be used alone or in combination with 
each other. Pikus et al published a 
prospective analysis of 72 patients in 1998 
and it suggested that microsurgery is better 
than radio surgery for AVM of grade 1–3 
according to the Spetzler Martin Grading.20 
This was also confirmed by Lunsford et al. 
who in 1991 published an interventional 
study that stated that microsurgery is the most 
effective method for AVM.21 Steiner et al in 
1993 performed a comparative study that 
discouraged the overuse of radiosurgery.22 
However, Firlik et al. in 1998, in a technical 
case report suggested that radiosurgery and 
microsurgical resection should be combined 
for grade 5 AVM.23 This had been 
contraindicated previously by Steinberg et al. 
in 1996 who in a clinical study stated that 
resection becomes more difficult after radio 
surgery but it went on to suggest that if radio 
surgery is done several years before surgery 
then it can be useful for large AVMs because 
they might be untreatable if a single treatment 
modality is used.24 A more recent 
retrospective cohort study done by 
Marciscano et a. which was published in the 
year 2017 was done to assess the long-term 
outcomes of repeat radio surgery. They 
concluded that high grade AVM can be 
treated with multistage radio surgery with 
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complete obliteration rate being 38%.25 Robin 
M. Starke et al in the year 2013 created the 
Virginia Radiosurgery Scale (VRS). 
Although, the Spetzler-Martin Grading is the 
most frequently used and quoted grading 
system, however, its elements which include 
size, venous drainage pattern and location are 
not accurate predictors of outcome in those 
who receive treatment with SRS. The VRS 
with three elements which included history of 
haemorrhage, AVM volume and AVM 
location was found to be mathematically 
more complex but in terms of accuracy it was 
more superior to the Setzler Martin grading.26 
3) Embolization- Mathis et al performed a 
retrospective study that was published in the 
year 1995. They found that geometry of the 
equipment and dose limitation led to a fall in 
the obliteration rate from 80% to 28% for 
AVM with a volume greater than 10 cm3 and 
a size greater than 2.7 cm treated with radio 
surgery alone. AVM which were treated with 
embolization and radiosurgery with size 
greater than 3 cm were found to have an 
obliteration rate of 50% with no permanent 
neurological deficits. And hence they 
concluded embolization before radiosurgery 
was a better option for large AVMs.27 
However, in the year 2007, 
Watanabe et a. published a clinical trial that 
suggested that radiosurgery alone is a better 
treatment modality as embolization decreases 
the obliteration rate. In the group that was 
treated with radiosurgery and embolization 
the obliteration rate was found to be 47% 
while in those treated with radiosurgery alone 
the obliteration rate was found to be 70%.28 
This was found due to recanalization of 
embolized AVM, difficult targeting and dose 
reduction due to high density material that is 
used.29 
In a more recent retrospective study done in 
2011 by Blackburn et al. it was found that that 
the obliteration rate was higher in large AVMs 
(greater than 3 cm) that were treated with a 
combination of embolization and radiosurgery 
being 81%.30 
Xu et al in the year 2014 performed a meta-
analysis that also confirmed that embolization 
decreases the obliteration rate. The group that 
received SRS and embolization (group 1) had 
an obliteration rate of 41% (group 2). While 
those who only underwent SRS the 
obliteration rate was 59%. The haemorrhage 
rate in group 1 was found to be 7.3% while 
that in group 2 was found to be 5.6%. 
Neurological deficits in group 1 were found to 
be 3.3% while those in group 2 were found to 
be 3.4%. However, statistically there was no 
difference in the haemorrhage rate and in 
occurrence of neurological deficits.31 
However, one of the limitations of the study 
that was mentioned was that most of the cases 
were retrospective and none of the studies had 
a randomized design. 
The material used for embolization also 
plays a role in the obliteration rate as 
particulate embolization may be found to have 
a risk of recanalization of the nidus.27 Onyx 
embolization has been found to be an 
alternative. Xu et al performed a clinical trial 
where instead of using the high-density 
material, Onyx embolization was used to 
reduce the size of AVM without significant 
complication. Complete obliteration was found 
in 18.6% of patients with large AVMs (greater 
than 3 cm) and a volume reduction of 80.5%. 
This study, however, had the limitation of not 
having a large sample size and patients were 
lost to follow-up.32 
Hence with regards to embolization 
there is some controversy, however, there is 
general consensus that using embolization 
before radiosurgery for large AVMs has a 
beneficial outcome.  
4) Intensity modulated radiotherapy 
(IMRT) Another treatment modality could be 
the use of IMRT. Optically guided technology 
provides improved patient localization and 
online monitoring of patient position during 
treatment delivery, it allows for safe and 
efficient delivery of intensity modulated 
radiotherapy.33 A clinical study was done to 
compare SRS with IMRT. It revealed that for a 
single small target both SRS and IMRT have 
comparable results. However, for AVM that 
are larger (greater than 4 cm) and more 
irregular IMRT seems to be more superior.34 
With radiosurgery, the entire target was 
covered by the 90.7% isodose line. The 
maximum dose within the target was 1.02 G. 
The coverage was 0.99. The homogeneity 
index (HI) was 1.13 and the conformity index 
was 4.1. With IMRT, the maximum dose 
within the target was 1.25 Gy. The coverage 
was 0.99. The HI was 1.25 and the CI was 
2.57.34 
Factors determining the outcome of SRS 
The outcome of radio surgery was determined by a 
number of factors. Small volume (less than 2 cm in 
diameter), hemispheric AVM and single session 
predict success after radio surgery with an AVM 
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obliteration rate of 80%.1 This is in conjunction with 
a meta-analysis and systemic review published in 
2014 by Xu et al. and that suggested that treatment 
failure occurred more frequently when AVM volume 
was greater than 10mL, lower dose 50cGy was used, 
there were multiple isocentres and previous 
haemorrhage history.31 Ellis et al in 1996 in a 
multivariate analysis looked at reasons for treatment 
failure after radio surgery and found that 72 patients 
attained angiographically confirmed cures after 
radiosurgery and 36 were retreated after the initial 
radio surgical treatment failed.35 L Dade Lunsford et 
al. performed a clinical trial that was published in the 
year 1991 and found that success and complication 
risks are related to the AVM location and the volume 
that needs to be treated. These complications 
included 6.7% of patients developing neurological 
deficits which were due to radiation induced injury, 
intracranial haemorrhage occurred in 4.7% of 
patients, however, post radio surgery seizure and 
headache frequency was seen to improve, with 
reduction of seizures in 51% of patients and headache 
improvement in 75% of patients.21  
A multivariate analysis published in 1999 
that was performed by Miyawaki et al. to assess the 
relationship of dose and volume to obliteration as 
well as to complications found that obliteration rate 
for volumes <4 mL was 67% and as volume 
increased the obliteration rate decreased and 
complication rate increased. There was also a greater 
incidence of radiation necrosis.36 This is however in 
contradiction to a previous study published in 1996 
by Flickinger et al. which stated that obliteration rate 
was related to minimum dose but it had no relation 
with volume or maximum dose.37 
A retrospective analysis published in 1995 
by Yamamoto et al. was done to find out the 
relationship between dose and volume. It revealed 
that malformations up to 30 cm3 in volume could be 
treated effectively with an acceptably low 
complication rate using a dose of 16 Gy.3  
In a multivariate analysis published in 1992 
by Flickinger et al it was found that volume was the 
only significant factor associated with the 
development of imaging changes on MRI which 
included new regions of increased T2 signal on 
MRI.38 
Pasquale Gallena et al performed a 
retrospective study that was published in the year 
1998, they found that that partial volume irradiation 
shouldn’t be done and aim of treatment should be to 
completely obliterate the nidus as this lead to an 
increased risk of haemorrhage which was because of 
the rise in the pressure gradient through the 
malformations.39 
An inferential analysis done by Karlsson et al that 
was published in 1997 stated that the probability of 
obliteration of AVMs after gamma knife surgery is 
related both to the lowest dose given to the AVMs and 
the AVM volume which can be predicted by K 
index.40 The obliteration rate was seen to increase as 
the K value increased up to a value of 27. 
Large AVMs are usually considered those 
that are larger than 30 cm3.41 Treatment becomes 
more difficult as size increase. There are many 
treatment options for such a situation e.g. repeated 
gamma radiation, stereotactic radio-surgery, staged 
volume radio-surgery, hypo fractionated stereotactic 
radiation (HSRT) and surgical excision. Yu et al did 
a clinical review in 2010 where they found out that 
repeated Gamma radiation should be considered as a 
treatment option for large AVMs. Even though this 
method had the disadvantage of taking longer but the 
complication and obliteration rate were quite 
acceptable. The overall obliteration rate was found to 
be 34.1%, the approximate obliteration rate in 120 
months was calculated to be 41.8%. Of 44 patients, 3 
(6.8%) experienced haemorrhages after GKS, cysts 
developed in 2 patients (4.5%), One patient (2.3%) 
experienced a newly developed seizure and another 
patient (2.3%) developed radiation necrosis.41 This is 
in concurrence with a retrospective study done in 
2009 that suggested that stereotactic radio-surgery is 
a safe and effective option for large sized AVM.42 
Prospective staged volume radio-surgery is also a 
treatment option that can be utilized for cases where 
no other therapy can be used.43 
Xiao et al in 2009 published a retrospective 
study that suggested that before single dose radio 
surgery, HSRT can be given and it had the advantage 
of not increasing the bleeding risk with the median 
AVM volume decreasing to a value of 13.51 cm3. 
But they also stated that future studies needed to be 
done to confirm their results.44 This was in line with a 
literature review published in 2012 by Wang et al. 
that stated that rate of AVM obliteration utilizing 
HSRT as a primary treatment was comparable with 
that of radio-surgery.45 Reinard et al in 2015 
published a clinical review on ‘Surgical management 
of giant AVM’ and suggested that surgery could be 
one of the treatment options since it caused complete 
obliteration in 90% of patients. But since giant 
AVMs have a high mortality rate a multimodal 
treatment approach should be used.46 
Friedman et al. in 2012 in a multi variate 
analysis suggested that lower Spetzler- Martin grade, 
higher dose and steeper dose gradient increased the 
success rate.4 This was in accordance with a 
multivariate analysis that treatment failure was 
because of increasing AVM size, decreasing 
treatment dose, and higher Spetzler Martin grade. 
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There was also an important factor that needed to be 
considered which was treating high grade AVM with 
planned multi stage dose or single dose. An 
interventional study done by Pollock et al published 
in the year 2000 suggested that staged volume radio 
surgery had the advantage of less radiation exposure 
to the adjacent brain. However, it also mentioned that 
further follow up will be required to find out if this 
technique provides high obliteration rate.47 A more 
recent article done to find long-term outcomes of 
mutli-stage dosage in 2017 by Marciscano et al found 
that this method achieves successful AVM 
obliteration with acceptable adverse effect rates.25 
This was in agreement with a retrospective study 
done by Iyas et al and was published in 2017. It 
suggested that volume staged stereo-static radio-
surgery was a good treatment option for large AVMs. 
There were no cases of post treatment haemorrhage 
and this approach was found to decrease the nidus 
size.48 The median AVM volume reduction was 
found to be 87%. 
A retrospective analysis was done by 
Pollock et al. published in 1996 to find out the 
reasons for incomplete obliteration. The most 
frequent factor turned out to be incomplete 
angiographic definition.49 This was also stated in a 
previously mentioned article that observed some 
errors in finding out AVM target shape and size. 
These errors were attributed to inaccurate definition 
of the nidus and because of incomplete stereo-
angiography.39 Rate of AVM obliteration depended 
on marginal dose and problems in dose response 
plateau were attributed to problems in target 
definition.50 
Outcome of radio-surgery was also 
dependant on the location of the AVM. Brain AVMs 
are classified into superficial and deep types. 
Superficial AVMs are further divided into sulcal, 
gyral, or mixed, while deep types that are relatively 
rare are subdivided into subarachnoid, deep 
parenchymal, plexal, and mixed types.51 In a 
retrospective review done by Kurita et al. published 
in the year 2000, it was stated that radio surgery is a 
good treatment option for small deep parenchymal 
brain stem AVMs.52 Ellis et al in 1996 in a 
multivariate analysis showed that radiosurgery is also 
a good treatment option for intracranial dural AV 
fistulas.35 However if the AVM is located at a deeper 
location it decreases the chance of radio-surgical 
success. Pollock et al in 2004 published a clinical 
study that was done for deeply located AVM 
revealed that there is difficulty in treating patients 
with deeply located AVMs and that most of them are 
also poor candidates for surgical resection or 
embolization.13 There was general consensus that 
radiosurgery is a good treatment modality for deep 
AVM however there was still some risk of latent 
haemorrhage in incompletely obliterated nidus.52  
Grade is also an important factor. A number 
of articles suggest that microsurgery is preferred for 
lower grade.20,21,26 Radio surgery with stereotactic 
MR targeting and multiplanar dose planning can be 
used for treatment of larger AVMs (30 cm3).53  
In children, different treatment options are 
considered. Capitanio et al in 2016, in a retrospective 
review suggested that stereotactic radiosurgery (SRS) 
at an optimum radiation dose of 18–25 Gy can be 
used as a safe and effective method for AVM.54 This 
is in agreement with a clinical study done by Yen et 
al. in 2010 that states that gamma knife radiosurgery 
at an optimum radiation dose of 21.9 Gy causes 
reasonable obliteration of AVM with decreased 
radiation induced adverse effects.55 Another clinical 
article by Blamek et al in 2013 states that stereotactic 
linac radiosurgery is an effective method for AVM in 
children. However, follow up is required because of 
the high incidence of radiation induced side effects.56 
This is in concurrence with Rajshekhar et al. who in 
2016 in a retrospective cohort study stated that a 
marginal dose of 15 Gy resulted in an obliteration 
rate of 66.7%.57 A univariate and multivariate 
analysis was done by Reyns et al. in 2007 in which 
they reviewed data from 100 children and suggested 
that radiosurgery is a safe method.58 
However, for high grade AVM in children 
the success rate of single dose SRS is limited and 
other treatment options should be explored. One 
option could be intensity-modulated radiosurgery 
(IMRS) for treatment of complex AVM which has 
favourable outcomes.7 A clinical trial done by Woo et 
al. in 1996 compared SRS with IMRS and stated that 
IMRS is superior to SRS for irregular shaped 
AVMs.34 This is in accordance with a literature 
review done by Sterzing et al in 2007. They stated 
that conventional radiotherapy has been associated 
with limited dose to the target and there is high risk 
of damage to normal tissues.59 
Complications 
Complications after radio surgery include 
haemorrhage, seizures, delayed cysts and other 
adverse effects. Factors that determine complications 
include clinical history, previous AVM surgery and 
previous radiation exposure.6 
During a mean post Gamma knife radio 
surgery (GKRS) follow up over a period of 10.2 
years, 15 (8.3%) of the 181 patients who underwent 
surgery experienced stereotactic radiosurgery related 
symptomatic complications. Among the 15 patients, 
12 manifested complications in 5 years or more after 
GKRS and in 5 of these 12 patients, complications 
were seen in 10 years or more after GKRS.6  
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Flickinger et al in 1998 in a multivariate analysis 
study suggested that the risk of complication can be 
predicted according to the PIE (post radiosurgery 
injury expression) score but other factors that may 
eventually lead to radiation necrosis still need to be 
researched.60 Results showed that symptomatic post 
radiosurgery sequelae developed in 30 (9%) of 332 
patients.  
Karlsson et al in 1998 suggested that risk of 
complication is not dependent on age or gender.6 In a 
study, published in 2005, from 201 patients who 
underwent radio surgery only 12 developed post 
treatment haemorrhage. Patient age was not related to 
post treatment bleeding.61 This was in concordance 
with the clinical study done by Karlsson et al. in 
1997 that stated complication risk is not dependent 
on age.6 However, Lv et al in a retrospective analysis 
of a case series of 496 patients in 2016 suggested that 
occurrence of subsequent haemorrhage from AVM 
was associated with younger age and female 
gender.62 
Pollock et al in 1996 did a multi variate 
analysis in which angiographic characteristics of 315 
patients after radio surgery were observed. It was 
found that patients who had complete obliteration did 
not experience hemorrhage.63 This was also 
confirmed by a univariate and multivariate analysis 
done by Nataf et al in 2004 that suggested that 
haemorrhage risk is increased in patients with poor 
obliteration levels.5 
Such was shown in a study where median 
clinical follow-up was 53.8 months. 47.6% of 
patients had an AVM with a Spetzler-Martin grade ≥ 
III. The median administered margin and maximum 
doses were 22 and 40 Gy, respectively. The overall 
obliteration rate was 70.5%. Of patients who showed 
complete obliteration, 74.4% developed adverse 
radiation effects within 4–6 months after GKRS.64 
Besides haemorrhage late adverse radiation 
effects (ARE) can occur after radio surgery.64 These 
include lesional oedema and cyst formation. 
Treatment usually involves resection of the 
thrombosed AVM.51 One article suggests that these 
adverse effects peak at 7–12 months.64 Late-onset 
ARE (i.e., >12 months) correlated to a failure to 
obliterate the nidus. 58.1% of patients who developed 
appreciable AREs (defined as ARE index >8) 
proceeded to have complete nidus obliteration. 
Appreciable AREs were found to be influenced by 
AVM nidus volume >3 ml, lobar location, number of 
draining veins and feeding arteries, prior 
embolization, and higher margin dose. On the other 
hand, a minimum ARE index >8 predicted 
obliteration (p=0.043) the study hence proved that 
ARE development after radiosurgery follows a 
temporal pattern peaking at 7–12 months after 
stereotactic radiosurgery and that ARE index serves 
as an important tool in patient follow-up and outcome 
prediction. 
  Cyst formation, although rare but a study 
mentioned a case where 3 years after radio surgery a 
24-year-old woman developed a cyst in the parietal 
lobe of her brain.44 Another older article also 
mentioned 2 case reports of delayed cyst formation.65 
In a Retrospective review of 233 AVM 
patients having SRS from 1990 to 2009. Patients had 
sporadic AVM, no prior radiation, and a minimum of 
5 years of magnetic resonance imaging (MRI) 
follow-up. The study showed that late ARE were 
observed in 16 patients (6.9%) at a median of 8.7 
years after SRS (range, 2.0–16.1). The 5, 10, and 15-
year incidence of late ARE was 0.4%, 7.7%, and 
12.5%, respectively. Eight patients (3.4%) were 
symptomatic at the time of ARE detection. Three of 8 
patients who were initially asymptomatic had 
documented cyst progression (at 11, 40, and 42 
months), for an overall symptomatic rate of 4.7%. 
Five patients with asymptomatic ARE have been 
observed for a median of 9.3 years (range, 2.0–14.1) 
without progression. Patients having early radiation 
induced changes RIC (hazard ratio [HR] = 2.11, p< 
.001), patients having obliteration (HR = 1.24, p= 
.02), and patients having SRS before April 1997 (HR 
= 1.12, p= .02) were more likely to develop late 
ARE.51 Therefore it was proved that late ARE are 
common in AVM patients who develop early RIC 
after SRS. Resection of the thrombosed AVM and the 
adjacent damaged tissue is effective at eliminating 
the mass effect and improving patients' neurological 
condition. 
A clinical study was done by Malikova et al 
in 2016 to determine late morphological changes 
after radio surgery. The study stated that Gamma 
knife radiosurgery for AVM is a safe treatment 
method but delayed complications cannot be avoided 
and were found. Also, post-gadolinium enhancement 
could be a sign of an active, delayed post-irradiative 
process.66 
Murray et al. in a cohort study published in 
the year 2014 discussed the Neuropsychological 
outcomes of hypo-fractionated stereotactic 
radiotherapy (HSRT) for AVM. It demonstrated that 
patients had memory improvement several years later 
and this form of treatment was not associated with 
long-term, harmful cognitive side effects.67 
Prior to HSRT treatment AVM showed 
deviations from the mean of the normal population in 
a number of cognitive domains measured. Five out of 
nine cognitive domains were impaired especially 
processing speed, learning, naming, verbal fluency, 
and executive functioning were mildly impaired. 
However, domains of semantic processing, memory, 
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attention and visuospatial function were in normal 
limits although the mean score of major cognitive 
domains we’re reaching impaired levels. Mild CNS 
toxicity is expected in HSRT treatment but in 
contrast to above cognitive domains remained stable 
during follow up assessments.67 
Follow up: 
The current standard for assessing obliteration after 
SRS is digital subtraction angiography (DSA). As of 
late MRI and MR angiography (MRA) have gained 
considerable popularity. A study was done to 
compare MRI with conventional angiography. The 
results of the study revealed that there was no 
difference in diagnosing the patency of AVM on 
MRI and with conventional angiography.68 
This is in contradiction to a more recent 
study that was done to find out the specificity and 
sensitivity of MRI/MRA. This study revealed that the 
sensitivity and specificity were in the range of 70–
95% and were not that low but still DSA should be 
used to confirm the obliteration rate.69 
CONCLUSION 
Considering the above literature, stereotactic radio 
surgery seems to be a good treatment modality due to 
its high obliteration rate and low complication risk. It 
was considered as a good option for tumours that had 
lesser volume but higher grade. Haemorrhage, 
seizures, headaches and neurological deficits occur 
less frequently and the complications of radio surgery 
are usually because of incomplete obliteration. 
However, for tumours with greater volume and larger 
size a multimodal approach can be considered such 
as microsurgery combined with radiosurgery, 
combined embolization and radiosurgery and 
intensity modulated radiotherapy. The latter being the 
preferred choice in children with higher grade and 
larger size of AVM. 
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